Ariel Sugarman, M.D.

Dr. Mario Gaudino is the Stephen and Suzanne Weiss Professor (II) in Cardiothoracic Surgery in the Department of Cardiothoracic Surgery at Weill Cornell Medicine - NY Presbyterian.Dr. Gaudino completed his undergraduate studies and earned his medical degree in Rome, Italy at the University of Rome, Faculty of Medicine and Surgery in 1994. He subsequently completed his residency in 1999 at the same University and joined the faculty there in 2000 where he remained until 2014, when he joined the Department of Cardiothoracic Surgery at Weill Cornell Medicine. He completed an Advanced Cardiovascular/Aortic Aneurysm Surgery Fellowship in 2016 and was recruited to stay on staff as Assistant Professor of Cardiothoracic Surgery. In 2017, he was elevated to the position of Professor in Cardiothoracic Surgery and Attending Cardiothoracic Surgeon at NY-Presbyterian Hospital.In addition to his clinical expertise, Dr. Gaudino is currently the Assistant Dean for Clinical Trials, Director for the Joint Clinical Trials Office (JCTO), and the Director of Translational and Clinical Research for the Department of Cardiothoracic Surgery. Throughout his academic career, Dr. Gaudino has published more than 700 peer-reviewed manuscripts in cardiothoracic surgery, cardiology and research methodology and public health in high impact journals including first author in the New England Journal of Medicine, the Lancet and the Journal of the American Medical Association along with numerous book chapters.He is currently the lead investigator of several international, randomized, cardiac surgery trials (ROMA, ROMA:Women, RECHARGE, STICH3C, SITCOS, ODIN, PALACS, EPIC).He currently serves as the Chair of the of the Council on Cardiovascular Surgery and Anesthesia CVSA Education and Publications Committee as well as the Chair of the Participant User File (PUF) Review Task Force of the Society of Thoracic Surgeons (Adult Cardiac Subcommittee). He also served as the Immediate past Chair of the Coronary Artery Surgery Task Force of the European Association for Cardio-thoracic Surgery.As a known advocate for scientific integrity and surgical quality, Dr. Gaudino is often called upon to serve on guideline writing committees to help set standards for cardiac surgery both nationally and internationally. He is a member of the AHA/ACC Joint Committee on Clinical Practice Guidelines, and recently served as Chair of the writing committee for Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery: A Scientific Statement From the American Heart Association.Dr. Gaudino’s interests include all aspects of adult cardiac surgery. Along with his expert training and knowledge in coronary artery bypass surgery, including the use of multiple arterial grafting (radial artery conduits, the use of bilateral internal mammary arteries), Dr. Gaudino also specializes in structural heart disease, valvular dysfunction and complex aortic procedures. Outside of the hospital, he enjoys running, traveling, and spending time with his cats and rabbit.

Dr. Lisa Roth is an Assistant Professor in the Departments of Pediatrics and Medicine at Weill Cornell Medicine. She is also the Director of the Adolescent and Young Adult Lymphoma Program at Weill Cornell Medicine/New York Presbyterian Hospital. Dr. Roth has been named the Charles, Lillian, and Betty Neuwirth Clinical Scholar in Pediatric Oncology. Dr. Roth completed her undergraduate work at Duke University. She received her medical degree from New York University School of Medicine. Dr. Roth conducted her residency at NewYork-Presbyterian/Weill Cornell and her fellowship in pediatric hematology/oncology at Memorial Sloan-Kettering Cancer Center and NewYork-Presbyterian where she served as chief fellow. Dr. Roth specializes in treating children, adolescents and young adults with lymphoma and leukemia. She is a member of the Childrens Oncology Group and an active participant in Hodgkin lymphoma and non-Hodgkin lymphoma clinical trials. She is also a member of the Weill Cornell Center for Lymphoma, a group which is internationally recognized for its leadership in the treatment of patients with lymphoma. Dr. Roths research focuses on identifying new treatments for children with lymphoma. She is particularly interested identifying novel targeted therapies. Targeted therapies may be less toxic than conventional chemotherapy and may be able to rescue those patients with chemotherapy-resistant disease. Dr. Roth has been recognized for her work with awards from the National Institutes of Health (NIH), the Lymphoma Research Foundation, Hyundai Hope on Wheels Foundation, and the St. Baldrick's Foundation. For More Videos, please see below: OR-Live: Treating AYA Patients with Hodgkins Lymphoma (5/10/2017)https://www.youtube.com/watch?v=PT-Qwg2EvqgLymphoma Cancer Treatment NY - Weill Cornell Dr. Roth In the News: Taking Away the Toll (12/2015)http://www.nyrr.org/races-and-events/2016/nyrr-new-york-mini-10k/lisa-roth